[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate

C40H54N6O9S — CID 140666505

IUPAC[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate
SMILES[2H]C([2H])([2H])C(OC(=O)N[C@@H]1C(=O)N2C[C@H](Oc3nccc4c5c(ccc34)N(C)CCO5)C[C@H]2C(=O)N[C@]2(C(=O)NS(=O)(=O)C3CC3)C[C@H]2/C=C\CC[C@H](C)C[C@H]1C)(C([2H])([2H])[2H])C([2H])([2H])[2H]
InChIInChI=1S/C40H54N6O9S/c1-23-9-7-8-10-25-21-40(25,37(49)44-56(51,52)27-11-12-27)43-34(47)31-20-26(22-46(31)36(48)32(24(2)19-23)42-38(50)55-39(3,4)5)54-35-29-13-14-30-33(28(29)15-16-41-35)53-18-17-45(30)6/h8,10,13-16,23-27,31-32H,7,9,11-12,17-22H2,1-6H3,(H,42,50)(H,43,47)(H,44,49)/b10-8-/t23-,24+,25+,26+,31-,32-,40+/m0/s1/i3D3,4D3,5D3
InChIKeyJGSKKLKLLPMDMD-KEJNYDMRSA-N
MW804.03 g/mol
LogP3.80
Rot. Bonds6

About [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate

[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate (PubChem CID 140666505) has the molecular formula C40H54N6O9S and a molecular weight of 804.03 g/mol. Its IUPAC name is [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate.

Molecular Properties

Compound Name[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate
PubChem CID140666505
Molecular FormulaC40H54N6O9S
Molecular Weight804.03 g/mol
Exact Mass803.42
IUPAC Name[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate
SMILES[2H]C([2H])([2H])C(OC(=O)N[C@@H]1C(=O)N2C[C@H](Oc3nccc4c5c(ccc34)N(C)CCO5)C[C@H]2C(=O)N[C@]2(C(=O)NS(=O)(=O)C3CC3)C[C@H]2/C=C\CC[C@H](C)C[C@H]1C)(C([2H])([2H])[2H])C([2H])([2H])[2H]
InChIInChI=1S/C40H54N6O9S/c1-23-9-7-8-10-25-21-40(25,37(49)44-56(51,52)27-11-12-27)43-34(47)31-20-26(22-46(31)36(48)32(24(2)19-23)42-38(50)55-39(3,4)5)54-35-29-13-14-30-33(28(29)15-16-41-35)53-18-17-45(30)6/h8,10,13-16,23-27,31-32H,7,9,11-12,17-22H2,1-6H3,(H,42,50)(H,43,47)(H,44,49)/b10-8-/t23-,24+,25+,26+,31-,32-,40+/m0/s1/i3D3,4D3,5D3
InChIKeyJGSKKLKLLPMDMD-KEJNYDMRSA-N
XLogP3.80
TPSA185.57 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500804.03
LogP ≤ 53.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate?
The IUPAC name of [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate (CID 140666505) is [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate.
What is the SMILES notation for [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate?
The canonical SMILES for [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate is [2H]C([2H])([2H])C(OC(=O)N[C@@H]1C(=O)N2C[C@H](Oc3nccc4c5c(ccc34)N(C)CCO5)C[C@H]2C(=O)N[C@]2(C(=O)NS(=O)(=O)C3CC3)C[C@H]2/C=C\CC[C@H](C)C[C@H]1C)(C([2H])([2H])[2H])C([2H])([2H])[2H].
What is the InChIKey of [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate?
The InChIKey is JGSKKLKLLPMDMD-KEJNYDMRSA-N. The full InChI is InChI=1S/C40H54N6O9S/c1-23-9-7-8-10-25-21-40(25,37(49)44-56(51,52)27-11-12-27)43-34(47)31-20-26(22-46(31)36(48)32(24(2)19-23)42-38(50)55-39(3,4)5)54-35-29-13-14-30-33(28(29)15-16-41-35)53-18-17-45(30)6/h8,10,13-16,23-27,31-32H,7,9,11-12,17-22H2,1-6H3,(H,42,50)(H,43,47)(H,44,49)/b10-8-/t23-,24+,25+,26+,31-,32-,40+/m0/s1/i3D3,4D3,5D3.
What are the key properties of [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate?
[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate has a molecular weight of 804.03 g/mol, XLogP of 3.80, 6 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl] N-[(1S,4R,6S,7Z,11S,13R,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-11,13-dimethyl-18-[(4-methyl-2,3-dihydropyrido[3,4-h][1,4]benzoxazin-7-yl)oxy]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate is sourced from PubChem (CID 140666505), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).